LOTEMAX
Google image searchProduct monograph
Active ingredient
loteprednol etabonate, 0.5 %/W/V
DIN: 02321114
Dosage form(s): SUSPENSION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: BAUSCH & LOMB INC
Date: 24-JUN-2009
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01B — ANTIINFLAMMATORY AGENTS (ATC, ATC/DDD)
- S01BA — Corticosteroids, plain (ATC, ATC/DDD)
- S01BA14 — LOTEPREDNOL (ATC/DDD)
Reference brand drug: Alrex, Lotemax
